Target intelligence / Profile preview

Immunosuppressive Factors in the Tumor Microenvironment (N/A)

Target
N/A
Molecular classification
Cytokines, Metabolites, Enzymes, Cell types, Environmental Factors
01

Overview

Immunosuppressive factors in the tumor microenvironment (TME) encompass a diverse set of molecules, cells, and metabolic conditions that collectively inhibit anti-tumor immune responses. These factors, produced by both tumor cells and various non-malignant cells within the TME, paralyze or suppress effector T cell activity, enabling tumors to evade immune surveillance and resist immunotherapy. Key examples include regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), cytokines like IL-10 and TGF-β, metabolites such as IDO and PGE2, and environmental factors like hypoxia and low pH. Overcoming these immunosuppressive barriers is a key focus for next-generation cancer therapies.

Other names
TME immunosuppressive factorsTumor-induced immunosuppressionImmune evasion mechanisms in cancerFactors suppressing anti-tumor immunity
02

Mechanism of action

Multiple mechanisms depending on the specific factor: inhibition of T-cell activation, induction of T-cell apoptosis, recruitment of immunosuppressive cells, suppression of antigen presentation, nutrient depletion, etc.

03

Biological functions

Immune suppressionT-cell inhibitionAngiogenesis promotionMetabolic regulationModulation of antigen presentation
04

Disease associations

CancerImmune evasionResistance to immunotherapy
05

Safety considerations

Immune-related adverse events (irAEs) associated with checkpoint inhibitorsPotential for promoting tumor growth if immunosuppression is not carefully modulatedDevelopment of resistance mechanisms to therapies targeting immunosuppressive factors
06

Interacting drugs

Anti-PD-1 antibodies (e.g., Nivolumab, Pembrolizumab)

5 more in the full profile.

07

Biomarkers

Treg infiltrationMDSC levelsTAM (M2) polarizationIDO expressionTGF-beta levelsVEGF levelsPD-L1 expression on tumor cells and immune cellsArginase I activityIL-10 levels

Beyond the preview

Go deeper on Immunosuppressive Factors in the Tumor Microenvironment (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunosuppressive Factors in the Tumor Microenvironment (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call